4.0 Letter

In Vitro Assessment of the Metabolic Stability of Two Novel Endomorphin-2 Analogs, CYX-5 and CYX-6, in Rat Liver Microsomes

Related references

Note: Only part of the references are listed.
Article Pharmacology & Pharmacy

CYX-5, a G-protein biassed MOP receptor agonist, DOP receptor antagonist and KOP receptor agonist, evokes constipation but not respiratory depression relative to morphine in rats

Mohammad Zafar Imam et al.

Summary: CYX-5 is a novel opioid peptide that acts as a G-protein biassed MOP receptor agonist, DOP receptor antagonist, and KOP receptor agonist. It provides pain relief, reduces stool output, and does not cause respiratory depression. The mechanism underlying its constipation effect may involve factors other than beta-arrestin2 recruitment.

PHARMACOLOGICAL REPORTS (2023)

Article Multidisciplinary Sciences

Retrospective assessment of rat liver microsomal stability at NCATS: data and QSAR models

Vishal B. Siramshetty et al.

SCIENTIFIC REPORTS (2020)

Article Chemistry, Medicinal

[Dmt1]DALDA analogues modified with tyrosine analogues at position 1

Yunxin Cai et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)

Article Chemistry, Medicinal

In Vitro Metabolic Stability and in Vivo Biodistribution of 3-Methyl-4-furoxancarbaldehyde Using PET Imaging in Rats

Adam B. Pippin et al.

ACS MEDICINAL CHEMISTRY LETTERS (2016)

Article Pharmacology & Pharmacy

Design, Synthesis and Pharmacological Characterization of Endomorphin Analogues with Non-Cyclic Amino Acid Residues in Position 2

Renata Perlikowska et al.

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2010)

Article Biochemistry & Molecular Biology

Biological activity of endomorphin and [Dmt1] endomorphin analogs with six-membered proline surrogates in position 2

Renata Perlikowska et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2009)

Review Biochemistry & Molecular Biology

Enzymatic degradation of endomorphins

Anna Janecka et al.

PEPTIDES (2008)